<DOC>
	<DOCNO>NCT02399358</DOCNO>
	<brief_summary>Prospoctive cohort high-dose cyclophosphamide expose patient . With active estandardize screen hyponatremia development follow period .</brief_summary>
	<brief_title>Factors Associated With Hyponatremia Induced High-dose Cyclophosphamide</brief_title>
	<detailed_description>Primary objective 1 . To identify factor associate development hyponatremia patient receive high-dose cyclophosphamide ( 2.5 gram ) . 2 . Generate validate predictive score develop hyponatremia high-dose cyclophosphamide . 3 . To estimate incidence hyponatremia patient undergo high-dose cyclophosphamide . Study design . Observational prospective cohort study Patients infusion high-dose cyclophosphamide . Follow period cyclophosphamide infusion one month hospital discharge .</detailed_description>
	<mesh_term>Hyponatremia</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<criteria>Adult patient ( 18 year ) admit Hematology / Oncology Medical Clinic Hospital Italiano de Buenos Aires infusion highdose cyclophosphamide conducting MSCH prior BMT , GATLA HyperCVAD period 20152017 . Refusal participate process informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Drug induce Hyponatremia</keyword>
	<keyword>Cyclophosphamide</keyword>
	<keyword>Hyponatremia</keyword>
	<keyword>Cyclophosphamide induce Hyponatremia</keyword>
</DOC>